Skip to main content
. 2012 Jul 27;14(9):1163–1170. doi: 10.1093/neuonc/nos146

Table 1.

Summary of general patient characteristics at enrollment (measurable tumor in eligible patients)

Patient Age (y) Sex Target Tumor Size Left/Right (mL) Prior Treatment of Left/Right Tumors Baseline WRS of Target Left/Right Tumor (%) Baseline PTA of Target Left/Right Tumor (dB)
1 22 F NA/7.72 S/S NA NA
2 21 M NA/26.80 S/None 4 46.25
3 13 M 1.54/0.61 None/None 84/NA 28.75/115.00
4 30 M NA/51.51 S/None NA NA
5 51 F 0.64/NA None/GK, S 4 55.00
6 28 M 15.39/NA None/RT, S 72 38.75
7 22 M 13.96/6.10 S/S NA/NA NA/NA
8 10 M 5.77/NA None/None 96 26.25
9 51 M 3.21/3.18 S, GK/S NA/92 NA/27.50
10 20 M NA/3.74 RT/RT NA 76.25
11 28 M NA/0.90 S/None 84 33.75
12 19 F 1.06/NA None/None 100 2.50
13 35 M NA/1.08 S/None 100 12.50
14 29 F 2.19/NA None/S 96 21.25
15 46 F NA/1.13 S/S NA NA
16 19 F 1.10/0.59 None/None 36/NA 66.25/NA
17 16 M 2.62/1.28 None/None 100/92 11.25/47.50

Abbreviations: F, female; M, male; S, surgery; GK, gamma knife; RT, radiation therapy; PTA, pure tone average; WRS, word recognition score; NA, not applicable (for WRS, NA indicates complete deafness).